Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy.
Bredin
H C
HC
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000368:Aged; D042944:Cholestenone 5 alpha-Reductase; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors; D018120:Finasteride; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase